Financials

  • Market Capitalization 4.63 M
  • Employee 1
  • Founded 2020
  • CEO N/A
  • Website liminatuspharma.com
  • Headquarter Delaware, United States
  • FIGI BBG01HVYG111
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4829
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
4.02 USD+14.53%+19.64%+16.18%+73.28%5.15 M USD
4832
XBIO
Xenetic Biosciences, Inc. - Common Stock
2.14 USD+0.47%-2.28%-46.50%-59.08%5.01 M USD
4847
XTLB
XTL Biopharmaceuticals Ltd - American Depositary Shares
1.95 USD-2.50%-8.45%-21.05%+117.15%4.61 M USD
4851
NCNA
NuCana plc - American Depositary Shares
1.08 USD-1.82%+1.89%-19.40%-49.77%4.49 M USD